Abstract
Binding studies with 125I-Tyr labelled hyaluronan (HA) on a cultured rat colon cancer cell line were performed to characterize the association of HA to tumour cells in vitro. Results show a specific and saturable binding (Kd= 1.36nM) which indicates the presence of an HA binding receptor on the tumour cells. There is a specific constant increase of cell-associated HA over time, which indicates that HA is specifically taken up by the cells through endocytosis. The binding of 125I-Tyr labelled HA was more effectively inhibited by unlabelled HA of high MW in relation to low MW species of the polysaccharide indicating that the receptor binds HA of high MW with greater affinity than low MW species. In competition experiments, the HA-binding could not be inhibited by other polysaccharides such as chondroitin sulphate and heparin. Nor could ligands for scavenger receptors and antibodies directed towards ICAM-1, CD 44 and RHAMM (Receptor for HA Mediated Motility) significantly inhibit the association of HA to tumour cells.
Similar content being viewed by others
References
Baumann H, Gauldie J (1994) Immunol Today 15: 74-80.
Van Dijk W, Turner, GA, Mackiewicz A (1994) Glycosyl Dis 1: 5-14.
Van Dijk W, Havenaar EC, Brinkman-Van der Linden ECM (1995) Glycoconjugate J 12: 227-33.
De Graaf TW, Van der Stelt ME, Anbergen MG, Van Dijk W (1993) J Exp Med 177: 657-66.
Wells C, Bùg-Hansen TC, Cooper EH, Glass MR (1981) Clin Chim Acta 109: 59-67.
Raynes J (1982) Biomedicine 36: 77-86.
Succari M, Foglietti M-J, Percheron F (1990) Clin Chim Acta 187: 235-42.
Brinkman-Van der Linden ECM, Havenaar EC, Van Ommen ECR, Van Kamp GJ, Gooren LJG, Van Dijk W (1996) Glycobiology 6: 407-12.
Mallet B, Franc JL, Miquel M, Arnaud C (1987) Clin Chim Acta 167: 247-57.
Mackiewicz A, Pawlowski T, Mackiewicz-Pawlowski A, Wiktorowicz K, Mackiewicz S (1987) Clin Chim Acta 163: 185-90.
Thompson S, Kelly CA, Gri¦ths ID, Turner GA (1989) Clin Chim Acta 184: 251-8.
De Graaf TW, Van Ommen ECR, Van der Stelt ME, Kerstens PJSM, Boerbooms AMTh, Van Dijk W (1994) J Rheum 21: 2209-16.
Dargan E, Thompson S, Cantwell BMJ, Wilson RG, Turner GA (1994) Glycosyl Dis 1: 37-44.
Havenaar EC, Dolhain RJEM, Turner GA, Goodarzi MT, Van Ommen ECR, Breedveld FC, Van Dijk W (1997) Glycoconjugate J 14: 457-65.
Katnik I, Goodarzi MT, Turner GA (1996) Glycoconjugate J 13: 1043-7.
Mancini G, Carbonara AO, Heremans JF (1965) Immuno-chemistry 2: 235-54.
Laemmli UK (1970) Nature 227: 680-5.
Van der Linden ECM, De Graaf TW, Anbergen MG, Dekker RM, Van Ommen ECR, Van den Eijnden DH, Van Dijk W (1994) Glycosyl Dis 1: 45-52.
Bùg-Hansen TC (1973) Anal Biochem 56: 480-8.
Brinkman-Van der Linden ECM, Van Ommen ECR, Van Dijk W (1996) Glycoconjugate J 13: 27-31.
Hodges LC, Laine R, Kai Chan S (1979) J Biol Chem 254: 8208-12.
Mega T, Lujan E, Yoshida A (1980) J Biol Chem 255: 4057-61.
Debray H, Montreuil J (1989) Carb Res 185: 15-26.
Brinkman-Van der Linden ECM, Mollicone R, Oriol R, Larson G, Van den Eijnden DH, Van Dijk W (1996) J Biol Chem 24: 14492-5.
Delers F, Strecker G, Engler R (1988) Biochem Cell Biol 66: 208-17.
Turner GA (1995) In Glycoimmunology (Alavi A, Axford JS, eds) pp 231-8. New York: Plenum Press.
Fournet B, Montreuil J, Strecker G, Dorland L, Haverkamp J, Vliegenthart JFG, Binette JP, Schmid K (1978) Biochemistry 17: 5206-14.
Bierhuizen MFA, De Wit M, Govers CARL, Ferwerda W, Koeleman C, Pos O, Van Dijk W (1988) J Biochem 175: 387-94.
Laine A, Hachulla E, Strecker G, Michalski J-C, Wieruszeski J-M (1991) Eur J Biochem 197: 209-15.
Dobryszycka W (1993) In Acute Phase Proteins: Molecular Biology, Biochemistry and Clinical Applications (Mackiewicz A, Kushner I, Baumann H, eds.) pp 185-206. Boca Raton: CRC Press.
Paulson JC, Prieels JP, Glasgow LR, Hill RL (1978) J Biol Chem 253: 5617-24.
Joziasse DH, Schiphorst WECM, Van den Eijnden DH, Van Kuik JA, Van Halbeck H, Vliegenthart JFG (1987) J Biol Chem. 262: 2025-33.
Nemansky M, Van den Eijnden DH (1993) Glycoconjugate J 10: 99-108.
Bennet M, Schmid K (1980) Proc Natl Acad Sci USA 77: 6109-13.
Pos O, Oostendorp RAJ, Van der Stelt ME, Scheper RJ, Van Dijk W (1990) Inflammation 14: 133-41.
Bories PN, Feger J, Benbernou N, Rouzeau J-D, Agneray, J, Durand G (1990) Inflammation 14: 315-23.
Lejeune P-J, Mallet B, Farnarier C, Kaplanski S (1989) Biochim Biophys Acta 990: 122-7.
Shiyan SD, Pukhal'skii AL, Toptygina AP, Nasonov VV, Bovin NV (1994) Bioorgan Khim 20: 994-1000.
Welply JK, Abbas SZ, Scudder P, Keene JL, Broschat K, Casnocha S, Gorka C, Steiniger C, Howard SC, Schmuke JJ, Graneto M, Rotsaert JM, Manger ID, Jacobs GS (1994) Glycobiology 4: 259-65.
Varki A (1994) Proc Natl Acad Sci USA 91: 7390-7.
Turunen JP, Majuri M-L, Seppo A, Tiisala S, Paavonen T, Miyasaka M, Lemström K, PenttiläL, Renkonen O, Renkonen R (1995) J Exp Med 182: 1133-42.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Samuelsson, C., Gustafson, S. Studies on the interaction between hyaluronan and a rat colon cancer cell line. Glycoconj J 15, 169–175 (1998). https://doi.org/10.1023/A:1006920323095
Issue Date:
DOI: https://doi.org/10.1023/A:1006920323095